The #1 Vegetable to Eat More Of to Reduce Visceral Fat, According to Dietitians
Reviewed by Dietitian Karen Ansel, M.S., RDNVisceral fat is deep belly fat that can raise the risk of diabetes, heart disease and more.
Eating carotenoid- and fiber-rich vegetables may help protect against this harmful fat.
Spinach is packed with these compounds, making it a top choice for reducing visceral fat.Visceral fat is the type of fat that lies deep in the abdomen and around the middle of the body. It's linked to a long list of chronic health conditions like type 2 diabetes, cardiovascular disease, metabolic syndrome and cancer. Lifestyle habits like exercise, sleep and stress management can play a key role in the amount of visceral fat your body accumulates. So can the foods you eat, especially vegetables. While many vegetables can help protect against this stubborn belly fat, dietitians say the best one of all is spinach.
Read on to find out what makes this leafy green so powerful, plus other simple tips to reduce troublesome visceral fat.
Spinach is rich in powerful plant compounds called carotenoids, especially lutein and zeaxanthin. 'Carotenoid-rich vegetables like spinach can potentially reduce visceral fat by increasing fat oxidation and reducing inflammation,' says Molly Synder, RDN, LDN. For instance, one study found that people with the highest serum concentrations of carotenoids in their blood, including lutein and zeaxanthin, had less visceral fat than people with the lowest levels.
'Carotenoid-rich vegetables [like spinach] are high in fiber and water, which promote fullness, reduce calorie intake and improve cholesterol levels often linked to visceral fat,' says Diane Han, M.P.H., RDN. In fact, research has found that people who eat a fiber-rich diet carry less visceral fat than those who consume little fiber. And spinach is a tasty way to get it. One cup of cooked spinach provides 4 grams of fiber or 14% of the 28-gram Daily Value.
People with obesity tend to have lower levels of carotenoids in their blood. However, research shows that higher carotenoid levels could help reduce their visceral and total body fat. For instance, one study found that when people's blood carotenoids rose, their body fat and waist circumference declined. While the exact reason isn't known for sure, carotenoids from foods like spinach may prevent the buildup of fat, including visceral fat. More research is needed to understand the exact mechanisms behind this process. But tossing some spinach into your salad or an omelet could be a tasty way to trim deep belly fat.
'Of course, carotenoids alone won't cause fat loss, but regularly including carotenoid-rich vegetables like spinach in meals, along with protein, fiber and healthy fats, supports a metabolic environment that can help reduce visceral fat over time,' says Anar Allidina, M.P.H., RDN. For even more visceral fat-reducing power, try these dietitian-approved strategies:
Get Moving. Both resistance training and aerobic exercise may be beneficial for reducing visceral fat. Fortunately, you don't have to spend hours in the gym to reap their benefits. 'Even short daily walks after meals reduce belly fat and blood sugar spikes,' says Allidina. The most important thing is consistency to prevent muscle loss over time.
Eat Enough Protein. 'Protein helps preserve lean muscle, supports metabolism and keeps you full,' says Allidina. The typical adult requires 0.36 grams of protein daily for each pound they weigh. For the biggest nutritional bang, eat a variety of protein-rich whole foods rather than supplements. And don't forget fiber-rich plant proteins like beans, tofu, edamame and lentils, which can benefit gut health and promote satiety.
Manage Stress. Living a high-stress lifestyle without the tools to manage it can take a toll on your health and contribute to excess visceral fat. That's because stress increases cortisol, a hormone that promotes fat accumulation around the abdomen. Stress-management techniques that include mindfulness and relaxation may help keep cortisol in check. 'Try deep breathing, yoga, journaling, time in nature or anything else that helps you feel calm and present,' says Allidina.
Limit Added Sugars. It's easy to eat too many added sugars, especially if you typically eat lots of highly processed foods or drink sugar-sweetened beverages. Trouble is, people who consume lots of added sugars tend to have more visceral fat than those who eat few added sugars. If you're wondering how much is too much, stick with the Dietary Guidelines for Americans recommendations of no more than 10% of total calories from added sugars. That's 50 grams of added sugars per day for someone who eats 2,000 calories daily.
Visceral fat can spell trouble for your health in all sorts of ways. Fortunately, certain foods can help reduce visceral fat or prevent it from creeping up in the first place. And spinach is a great place to start. In fact, spinach is dietitians' favorite vegetable for reducing visceral fat. This nutritious leafy green is filled with carotenoids that may inhibit fat storage and fight visceral fat-promoting inflammation. It also provides fiber, which has been linked to lower visceral fat levels and helps keep you full and satisfied. Plus, spinach is super-versatile. Whether you like it blended into a smoothie, piled high in a leafy green salad, tucked into a sandwich or stirred into soup, pasta or eggs, there are countless ways to enjoy this good-for-you leafy green. So, toss a bunch in your shopping cart today!
Read the original article on EATINGWELL

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
43 minutes ago
- CNN
SCOTUS orders judges to revisit decisions on transgender health plans, birth certificates in wake of blockbuster ruling
The Supreme Court on Monday tossed aside a handful of lower court rulings that sided with transgender Americans, requiring that judges in those cases revisit their decisions in the wake of a blockbuster ruling this month that upheld a ban on gender-affirming care for trans youth. The justices upended rulings that blocked state policies excluding coverage for gender-affirming care in state-sponsored health insurance plans. In a loss for the transgender Americans who sued, those decisions will now be reviewed again. The high court also upended an appeals court ruling that went against Oklahoma in a challenge to the state's effort to ban transgender residents from changing the sex designation on their birth certificates. Lower courts must now review the trio of cases again in light of the Supreme Court's major decision on June 18 that upheld Tennessee's ban on puberty blockers and hormone therapy for trans minors. The 6-3 ruling in US v. Skrmetti steered clear of discussion about other laws involving transgender Americans, but it also did little to protect them in other cases. The court ruled that Tennessee had not discriminated on the basis of sex, which gave the state far more room to regulate medical care. The court also held that the law did not discriminate on the basis of transgender status. This story is breaking and will be updated.
Yahoo
an hour ago
- Yahoo
Many People Actually Lose Muscle on a GLP-1. It's Not Too Hard to Avoid—Here's How.
MANY MEN STARTING GLP-1 medications like semaglutide or tirzepatide are trying to lose visceral fat. I've seen this in my work with clients as a dietitian. And targeting visceral fat is a good thing. That's because it's the kind of fat that wraps around your organs and raises your risk for heart disease, diabetes, and other health complications. But here's the thing: Unless you have the right plan, some of the weight you might lose on a GLP-1 might be hard-earned muscle. Recent research suggests that without lifestyle support, such as strength training and adequate protein intake, patients on GLP-1s can lose up to 40 percent of their total body weight, primarily from lean muscle mass rather than fat. Not only could that mean a loss of muscle mass, but a slower metabolism, too. (Not to mention a body composition recovery hill that sucks to climb.) But notice how above I mentioned the right plan? Well, here's that plan—for cutting visceral fat and keeping muscle. Think of your body like a team. GLP-1, a hormone, is your assistant coach that helps everything work together better. It helps you feel full faster, curbs your appetite, and keeps your blood sugar in check. Medications like semaglutide work by mimicking this hormone, lowering your drive to overeat and helping you manage your overall weight more effectively. Except in turning down the hunger signal, a GLP-1 med may also cause you to not consume enough of the right things. Namely protein. "It's criminal to put someone on a GLP-1 and not put them on a dietary plan," says Phil Vella, founder of Vita Bella Clinics, which operates over 35 weight-loss clinics across the U.S. "Protein is the single most important thing for them to [eat] when taking a GLP-1.' That's because protein is a major building block of muscle. Consume the right amount daily, and you maintain the muscle you have (and, depending on the conditions, grow more). Come up short and muscle loss can happen. The right plan involves a little math, a few adjustments, and some effort. That said, it'll reward you with greater strength and power. How do you know? Find out if that clinic has a registered dietitian on staff or can refer patients to one. Because the goal isn't just to lose weight. It's to keep what matters most while you're doing it. Aim for 1.6 to 2.0 grams of protein per kilogram of body weight per day (which is roughly 0.8 to 1 gram per pound). For a 175-pound guy, that's approximately 140 to 160 grams daily. And don't dump it all into one meal. Distribute your protein evenly, targeting 30 to 40 grams per meal. Leucine—an essential amino acid found in meat, dairy, and whey protein—triggers muscle growth. Prioritize proteins like eggs, fish, Greek yogurt, and beef. For plant-based eaters, be strategic and combine grains and legumes, or consider adding tofu to achieve a complete amino acid profile. Protein shakes, cottage cheese, high-protein yogurts, and foods with added protein and fiber can help bridge the gap, especially when your hunger is low. I love items that have 20-plus grams of protein and 5-plus grams of fiber. Muscle is a "use it or lose it" type of asset. Train with intention at least three times a week. Prioritize resistance training to signal to your body: "Hey, this tissue is still needed.' You Might Also Like The Best Hair Growth Shampoos for Men to Buy Now 25 Vegetables That Are Surprising Sources of Protein
Yahoo
an hour ago
- Yahoo
industryGENOME Unveils Groundbreaking Clinical Trial PAO Market Map Report, Powered by AI-Assisted Market Intelligence
TAMPA, Fla., June 30, 2025--(BUSINESS WIRE)--industryGENOME, a cutting-edge analytics firm specializing in granular precision insights, has released its first-ever Clinical Trial Patient Access Organization (PAO) Market Map Report, developed in collaboration with WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, and Crosstree. This report offers an unparalleled bottom-up analysis of the PAO sector, using AI-powered classification models to predict private company revenue and stratify market estimates across geographies, subsidiaries, and specialized capabilities. Transforming Industry Analysis with AI-Assisted Precision Leveraging its proprietary Industry Capabilities Classification System (ICCS®), industryGENOME provides a standardized and globally applicable framework for categorizing businesses. The ICCS® methodology enhances financial analysis, investment decision-making, and strategy development across the life sciences and healthcare industries. The report was developed in close collaboration with WCG, which played a pivotal role in identifying global industry participants to ensure the most comprehensive market representation. Crosstree assisted industryGENOME in industry classification quality assurance and predictive modeling, enhancing the precision of market insights. "This report is the most sophisticated analysis of the clinical trial PAO sector to date," said Shane Senior, Managing Director at Crosstree. "industryGENOME's AI-driven predictive engines achieve 85% classification accuracy, surpassing human classifiers, and ensuring the most precise industry intelligence for investors and market participants. The ability to scale this precision across large data sets is unprecedented." Key Findings from the Clinical Trial PAO Market Map Report Total Market Revenue: $14.95 billion Industry Participants: Over 3,000 global Patient Access Organizations with detailed company profiles for each Industry Stratification: Freestanding, Mobile, Virtual, Provider Embedded, and Service Embedded Sites Top Industry Players: Velocity, IQVIA, PPD, AES, CenExel Clinical Research, ERG, Javara Advanced Market Mapping: AI-assisted data collection and synthesis for high-fidelity revenue estimates allowing for "sum-of-the-parts" bottom-up market sizing Geo-Stratification Analysis: The United States leads with $10.6 billion in revenue, followed by the UK, Germany, and Australia Why This Report Sets a New Standard industryGENOME's bottom-up methodology, empowered by machine learning and predictive analytics, provides unprecedented insights into the PAO sector. The firm's mapped markets process, which identifies, collects, and analyzes micro-industry data, ensures highly precise revenue estimates, critical for investors, procurement specialists, and drug developers seeking strategic market positioning. Access the Report Today To access the Clinical Trial PAO Market Map Report, visit or contact Jordan Schiding at About industryGENOME industryGENOME is a market intelligence platform for the Health Sciences industry that continuously collects and analyzes millions of data points on pharma services companies, investors, deals, valuations, research, conferences, and news. It produces bottom-up market research reports and company profiles by combining AI with the expertise of industry investment professionals. The platform is distinguished by a proprietary, highly granular taxonomy that categorizes industry participant capabilities through defined relationships. This classification system delivers clean, precise, and actionable insights on the Health Sciences market. Using AI technologies—including natural language processing, machine translation, and supervised machine learning—industryGENOME classifies and curates data. In partnership with Crosstree, the platform trains its classification algorithm for accuracy and precision. Together, they are mapping the Health Sciences market one company at a time to deliver detailed, bottom-up industry segment insights. Learn more at About Crosstree Crosstree is a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the life sciences and healthcare industries: pharmaceutical services, diagnostics and tools, and digital health. Since 2004, Crosstree has advised on more completed transactions in these collective subsectors than any other investment bank. The firm provides clients a full suite of advisory and capital raising services, including both buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstree's narrow industry focus provides clients the expertise common of a bulge-bracket investment banking firm to middle-market companies and investors, with unparalleled industry insights, well-established strategic relationships across the globe and superior access to capital markets. From our offices in Tampa, Florida, Crosstree has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion. About WCG WCG is at the forefront of accelerating clinical research worldwide, serving as the trusted and preferred partner to biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and site partners. Offering a unique combination of expertise, next-generation data and insights, and tech-enabled solutions, WCG reduces complexity and optimizes study operations and outcomes while maintaining the highest standards of human participant protection. For more than 55 years, WCG has maintained a relentless commitment to efficiency, safety, and impact, empowering clinical trials to deliver life-improving therapies swiftly. For more information, please visit or follow us on LinkedIn or X @WCGClinical. View source version on Contacts industryGENOME and Crosstree Media Contact: Hillary McCutcheonFreshwater Marketing813.992.1470hillary@ WCG Media Contact: Carmin Gade, PhDChief Marketing Officer, WCG484.351.9959cgade@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data